SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

TherapeuticsMD (TXMD) Reports Third-Quarter 2026 Results

TherapeuticsMD reported financial results for the three months ended September 30, 2026. The supplied release text contains no figures for the listed financial results.Material DetailsContext by AI AnalystThis is a quarterly update from a company that shifted to collecting pharmaceutical royalties…

TXMD

Related stories